Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Prevalence of HIV among injection drug users in Georgia.

Chikovani I, Goguadze K, Ranade S, Wertlieb M, Rukhadze N, Gotsadze G.

J Int AIDS Soc. 2011 Feb 15;14:9. doi: 10.1186/1758-2652-14-9.

2.

Determinants of risky sexual behavior among injecting drug users (IDUs) in Georgia.

Chikovani I, Goguadze K, Bozicevic I, Rukhadze N, Gotsadze G.

AIDS Behav. 2013 Jun;17(5):1906-13. doi: 10.1007/s10461-012-0296-9.

PMID:
22968396
3.

Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.

Shapatava E, Nelson KE, Tsertsvadze T, del Rio C.

Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S35-8.

PMID:
16769443
4.

Behavioural risk factors and HIV infection of injection drug users at detoxification clinics in Puerto Rico.

Robles RR, Colón HM, Díaz N, Cancel LI, MacGowan R, Cole GE, Allen DM.

Int J Epidemiol. 1994 Jun;23(3):595-601.

PMID:
7960388
5.

Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.

Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV.

Addiction. 2006 Feb;101(2):252-66.

PMID:
16445554
6.

Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.

Vicknasingam B, Narayanan S, Navaratnam V.

Drug Alcohol Rev. 2009 Jul;28(4):447-54. doi: 10.1111/j.1465-3362.2009.00087.x.

PMID:
19594801
7.

A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.

Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML.

BMC Public Health. 2011 May 19;11:351. doi: 10.1186/1471-2458-11-351.

8.

Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran.

Hosseini M, SeyedAlinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, Jahani M, Seyed Ahmadian M, Payvarmehr F, Mohraz M, Emadi Koochak H, McFarland W.

Arch Iran Med. 2010 Jul;13(4):318-23. doi: 010134/AIM.0012.

9.

Correlates of HIV infection among young adult short-term injection drug users.

Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D.

AIDS. 2000 Apr 14;14(6):717-26.

PMID:
10807195
10.

Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.

Tran SD, Williams AB, Truong HT, Do NH.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):283-7.

PMID:
9495230
11.

HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.

de la Fuente L, Toro C, Soriano V, Brugal MT, Vallejo F, Barrio G, Jiménez V, Silva T; Project Itínere Working Group..

J Clin Virol. 2006 Mar;35(3):244-9.

PMID:
16143565
13.

Trends in human immunodeficiency virus infection among drug users in a detoxification unit.

Muga R, Sanvisens A, Egea JM, Tor J, Rey-Joly C.

Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S404-9.

PMID:
14648455
14.
15.

Was the 1988 HIV epidemic among Bangkok's injecting drug users a common source outbreak?

Wright NH, Vanichseni S, Akarasewi P, Wasi C, Choopanya K.

AIDS. 1994 Apr;8(4):529-32.

PMID:
8011258
16.

Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran.

Kheirandish P, Seyedalinaghi SA, Hosseini M, Jahani MR, Shirzad H, Foroughi M, Ahmadian MR, Jabbari H, Mohraz M, McFarland W.

J Acquir Immune Defic Syndr. 2010 Feb;53(2):273-5. doi: 10.1097/QAI.0b013e3181be6dde.

PMID:
20104123
17.

Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.

Barrio G, De La Fuente L, Toro C, Brugal TM, Soriano V, Gonzalez F, Bravo MJ, Vallejo F, Silva TC; Project Itinere Group..

Epidemiol Infect. 2007 May;135(4):592-603.

18.

Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence.

Platt L, Rhodes T, Hickman M, Mikhailova L, Lisetsky K, Sarang A, Lewis K, Parry J.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):623-31. doi: 10.1097/QAI.0b013e318165dbf7.

PMID:
18209680
19.

Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran.

Zamani S, Kihara M, Gouya MM, Vazirian M, Ono-Kihara M, Razzaghi EM, Ichikawa S.

AIDS. 2005 Apr 29;19(7):709-16.

PMID:
15821397
20.

Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.

de la Fuente L, Bravo MJ, Toro C, Brugal MT, Barrio G, Soriano V, Vallejo F, Ballesta R; Project Itinere Group..

J Epidemiol Community Health. 2006 Jun;60(6):537-42.

Supplemental Content

Support Center